PT. Polychem Indonesia Valuation
Is P2I undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of P2I when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: P2I (€0) is trading below our estimate of fair value (€0.01)
Significantly Below Fair Value: P2I is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for P2I?
Key metric: As P2I is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is P2I's PS Ratio? | |
|---|---|
| PS Ratio | 0.3x |
| Sales | US$104.89m |
| Market Cap | US$29.21m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.2x |
| Enterprise Value/EBITDA | -36.2x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does P2I's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.4x | ||
IBU IBU-tec advanced materials | 0.6x | 19.2% | €27.4m |
SIM0 SIMONA | 0.6x | n/a | €345.0m |
DLX Delignit | 0.3x | 10.2% | €23.8m |
NSAK OTI Greentech | 0.03x | n/a | €472.4k |
P2I PT. Polychem Indonesia | 0.3x | n/a | €462.8b |
Price-To-Sales vs Peers: P2I is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.4x).
Price to Sales Ratio vs Industry
How does P2I's PS Ratio compare vs other companies in the European Chemicals Industry?
Price-To-Sales vs Industry: P2I is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Chemicals industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is P2I's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate P2I's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Compañía de Minas BuenaventuraA
US$3.1b
Engages in the exploration, development, construction, and operation of mineral processing business.
MBU
US$11.70
7D
0%
1Y
35.3%
Mitsubishi Chemical Group
JP¥1.1t
Provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally.
M3C
JP¥4.86
7D
-2.7%
1Y
-15.9%
African Rainbow Minerals
R31.2b
Through its subsidiaries, operates as a diversified mining and minerals company in South Africa, Malaysia, and Switzerland.
EB9
R8.30
7D
-2.9%
1Y
-10.3%